Medicare Enrolled
Dr. Zeeshan Khan, MD
Family Medicine - Adult · Oceanside, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Zeeshan Khan is a family medicine - adult specialist in Oceanside, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 2,865 Medicare services across 1,328 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $7,620 from 53 pharmaceutical and/or device companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine - adult. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 14% volume in NY
$7,620 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,865
Medicare services
Top 14% in NY for family medicine - adult
1,328
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~220 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
749 | $65 | $221 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
705 | $66 | $247 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
455 | $38 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
323 | $112 | $425 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
136 | $168 | $580 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $67 | $265 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
78 | $195 | $570 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
69 | $114 | $401 |
| Home visit, new patient, low complexity A home visit for a new patient involving a low level of medical decision making. The visit lasts at least 30 minutes when time is used to determine the level of service. |
40 | $64 | $260 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
39 | $152 | $431 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
38 | $119 | $406 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
26 | $13 | $55 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
24 | $36 | $83 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
22 | $76 | $195 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
16 | $2 | $10 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
15 | $99 | $362 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,620
Total received (2018-2024)
Avg $1,089/year across 7 years
Top 11% in NY for family medicine - adult
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,620 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,348
2023
$1,495
2022
$1,677
2021
$1,039
2020
$347
2019
$812
2018
$902
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$219
Otsuka America Pharmaceutical, Inc.
$203
ABBVIE INC.
$150
PFIZER INC.
$113
Novo Nordisk Inc
$104
Boehringer Ingelheim Pharmaceuticals, Inc.
$103
Lilly USA, LLC
$94
Lundbeck LLC
$38
Avvisto Therapeutics, LLC
$34
Mylan Specialty L.P.
$32
Amgen Inc.
$32
Harmony Biosciences Llc
$25
Axsome Therapeutics, Inc.
$24
Ardelyx, Inc.
$23
Novartis Pharmaceuticals Corporation
$23
Takeda Pharmaceuticals U.S.A., Inc.
$21
SANOFI-AVENTIS U.S. LLC
$20
E.R. Squibb & Sons, L.L.C.
$20
Abbott Laboratories
$19
GlaxoSmithKline, LLC.
$19
Currax Pharmaceuticals LLC
$16
Exact Sciences Corporation
$16
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$867
PFIZER INC.
$771
Lilly USA, LLC
$733
ABBVIE INC.
$729
AstraZeneca Pharmaceuticals LP
$626
Boehringer Ingelheim Pharmaceuticals, Inc.
$425
Otsuka America Pharmaceutical, Inc.
$381
Novartis Pharmaceuticals Corporation
$349
Janssen Pharmaceuticals, Inc
$308
AbbVie Inc.
$223
Amgen Inc.
$217
Avanir Pharmaceuticals, Inc.
$143
Abbott Laboratories
$117
Allergan Inc.
$111
Collegium Pharmaceutical, Inc.
$101
Merck Sharp & Dohme Corporation
$98
IDORSIA PHARMACEUTICALS US INC
$97
Endo Pharmaceuticals Inc.
$95
Astellas Pharma US Inc
$95
Merck Sharp & Dohme LLC
$94
Exact Sciences Corporation
$82
Amarin Pharma Inc.
$81
Boston Scientific Corporation
$68
E.R. Squibb & Sons, L.L.C.
$49
Ardelyx, Inc.
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$48
Lundbeck LLC
$38
Takeda Pharmaceuticals U.S.A., Inc.
$36
Esperion Therapeutics, Inc.
$36
Avvisto Therapeutics, LLC
$34
GlaxoSmithKline, LLC.
$33
UCB, Inc.
$33
Sunovion Pharmaceuticals Inc.
$33
Mylan Specialty L.P.
$32
Scilex Pharmaceuticals Inc.
$30
ARBOR PHARMACEUTICALS, INC.
$27
Genentech USA, Inc.
$25
Harmony Biosciences Llc
$25
Axsome Therapeutics, Inc.
$24
Biohaven Pharmaceutical Holding Company Ltd.
$23
West-Ward Pharmaceuticals
$22
Allergan, Inc.
$21
Hikma Pharmaceuticals USA
$21
Daiichi Sankyo Inc.
$21
Kowa Pharmaceuticals America, Inc.
$20
Otsuka Pharmaceutical Development & Commercialization, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$20
Bioventus LLC
$17
Currax Pharmaceuticals LLC
$16
Ironwood Pharmaceuticals, Inc
$15
VistaPharm, Inc.
$14
Intercept Pharmaceuticals, Inc.
$13
Qiagen, LLC
$12
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · APTIOM · Aimovig · Auvelity · BELSOMRA · BREO · BREZTRI · BYSTOLIC · Briviact · CHANTIX · COMIRNATY · CONTRAVE · CREON · CYCLOSET · Cimzia · Cologuard Collection Kit · DUZALLO · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Exogen Ultrasound Bone Healing System · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · GLASSIA · General - Pain Management · IBSRELA · INJECTAFER · JANUVIA · JARDIANCE · LEQVIO · LINZESS · LOKELMA · LYRICA · Levemir · Livalo · MOUNJARO · Mitigare · Myrbetriq · NASCOBAL · NEXLETOL · NUEDEXTA · NURTEC ODT · Nuedexta · OCALIVA · Otezla · Ozempic · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Proclaim Family of SCS IPGs · QUANTIFERON-TB GOLD PLUS · QULIPTA · QUVIVIQ · REXULTI · Repatha · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYNJARDY · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Thyquidity · UBRELVY · VESICARE · VIBERZI · VRAYLAR · Vascepa · Veozah · WAKIX · XARELTO · XIFAXAN · XTAMPZA · Xofluza · YUPELRI · ZENPEP · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Family medicine - adults within 10 mi
92
Per 100K population
6.6
County median income
$143,408
Nearest hospital
MOUNT SINAI SOUTH NASSAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NY), with low-engagement industry engagement in the top 11% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Khan performed 749 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $7,620 from 53 companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other family medicine - adults in Oceanside?
Dr. Khan's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Family Medicine - Adults in Oceanside
Browse family medicine - adults in Oceanside ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine - Adults in NY
Family medicine - adults ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine - Adults in NY
Which NY family medicine - adults receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology